Editorial ArticleDrug Discovery & Development
Can new approach methodologies improve clinical trial success rates?
Read insights from an expert panel discussing the path towards making human-specific NAMs routine in preclinical research
News & Articles
Results per page
25
6 Articles Found | Selected Filters:
Editorial ArticleLife Sciences
Ready-to-use iPSC-derived cells transform CRISPR-based functional genomics
Discover how bit.bio's CRISPR-Ready ioCells eliminate months of cell line development
Product NewsLife Sciences
CRISPR-Ready ioGlutamatergic Neurons
Product NewsLife Sciences
bit.bio launches two new human cell disease models to advance discovery and development of treatments for Duchenne muscular dystrophy (DMD)
Models will be used to investigate, screen for and develop therapies for the restoration of dystrophin, the protein that is missing in DMD patients
Industry NewsLife Sciences
bit.bio launches Huntington’s disease human cell model
First neurodegenerative disease model launched from bit.bio's new ioDisease Model portfolio.
Product NewsLife Sciences
bit.bio launches first supply of consistent, scalable, human muscle cells
Highly consistent and scalable supply of lab grown human skeletal muscle cells provide an effective and biologically relevant tool for research and drug development